Armed with $9.4 million in Series A funding and strong clinical and industry connections, Satisfai Health plans to launch Certai…
Browsing: Curated GI articles
Artificial intelligence (AI) is revolutionizing the diagnosis and management of inflammatory bowel disease (IBD), addressing long-standing challenges like diagnostic inconsistency…
Walgreens Boots Alliance (WBA.O) is reportedly in advanced talks to sell itself to private equity firm Sycamore Partners, marking another…
At The Liver Meeting 2024, researchers unveiled an AI-driven algorithm capable of detecting early-stage metabolic dysfunction–associated steatotic liver disease (MASLD)…
Artificial intelligence is revolutionizing medicine, making healthcare more accurate and cost-effective, as highlighted in a recent editorial by The Washington…
A recent study led by Dr. Adam Rodman at Beth Israel Deaconess Medical Center revealed surprising insights into the use…
SpaceGut, a new company backed by SOL Partnership, has launched Malaysia’s first AI-powered at-home gut health test service. The service…
Mainz Biomed has partnered with Thermo Fisher Scientific to jointly develop and potentially commercialize a next-generation mRNA-based colorectal cancer screening…
AI-assisted colonoscopy has shown promise in enhancing adenoma detection rates, but it also significantly increases the removal of benign, non-adenomatous…
Ohio-based Summa Health has confirmed its acquisition by venture capital firm General Catalyst for $485 million. The deal, which is…